Related Experiment Video
Updated: Aug 4, 2025

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
Published on: March 26, 2018
Impact of the COVID-19 pandemic on aortic valve replacement procedures in Germany
Adrian Heidenreich1,2, Peter Stachon1,2, Vera Oettinger1,2
1Medical Centre, Department of Cardiology and Angiology, Faculty of Medicine, University of Freiburg, University Heart Centre Freiburg - Bad Krozingen, University of Freiburg, Freiburg, Germany.
Insights
COVID-19 significantly postponed aortic valve replacement (AVR) procedures in Germany, with surgical AVR (sAVR) cases deferred more than transcatheter AVR (TAVR). Postponements were less severe during the second pandemic wave.
Area of Science:
- Cardiology
- Public Health
- Health Services Research
Background:
- The COVID-19 pandemic led to widespread deferral of elective medical procedures, creating potential backlogs.
- Aortic valve replacement (AVR) procedures, including surgical AVR (sAVR) and transcatheter AVR (TAVR), are crucial interventions often requiring elective scheduling.
Purpose of the Study:
- To estimate the number of postponed surgical aortic valve replacement (sAVR) and transcatheter aortic valve replacement (TAVR) procedures in Germany during the initial phases of the COVID-19 pandemic.
- To quantify the impact of the pandemic's first two waves on AVR procedure volumes.
Main Methods:
- Utilized German national health records to identify all isolated sAVR and TAVR procedures performed between 2007 and 2020.
- Developed a predictive forecast for 2020 AVR procedures based on 2017-2019 weekly data.
- Compared the forecasted 2020 AVR volumes with the observed number of procedures to determine the reduction.
Main Results:
- Analysis included 225,398 sAVR and 159,638 TAVR procedures from 2007-2020.
- Overall AVR procedures (sAVR and TAVR) in Germany decreased by 19.07% in 2020 compared to projections.
- The first pandemic wave (weeks 12-21) saw a 32.06% weekly reduction, while the second wave (weeks 41-52) showed a 25.58% reduction.
- sAVR procedures experienced a greater decline (24.63%) than TAVR procedures (16.42%) for the entirety of 2020.
Conclusions:
- The initial year of the COVID-19 pandemic resulted in a substantial postponement of AVR procedures in Germany.
- The deferral rate was higher for sAVR compared to TAVR.
- The impact of procedure postponement was less pronounced during the second wave of the pandemic compared to the first.
Background:
COVID-19 has caused the deferral of millions of elective procedures, likely resulting in a backlog of cases. We estimate the number of postponed surgical aortic valve replacement (sAVR) and transcatheter aortic valve replacement (TAVR) procedures during the first two waves of the COVID-19 pandemic in Germany.
Methods:
Using German national records, all isolated TAVR and sAVR procedures between 2007 and 2020 were identified. Using weekly TAVR and sAVR procedures between 2017 and 2019, we created a forecast for 2020 and compared it with the observed number of procedures in 2020.
Results:
In Germany, a total of 225,398 isolated sAVR and 159,638 isolated TAVR procedures were conducted between 2007 and 2020 that were included in our analysis. The reduction in all AVR procedures (sAVR and TAVR) for the entire year 2020 was 19.07% (95%CI: 15.19-22.95%). During the first wave of the pandemic (week 12-21), the mean weekly reduction was 32.06% (23.44-40.68%) and during the second wave of the pandemic (week 41-52), the mean weekly reduction was 25.58% (14.19-36.97%). The number of sAVR procedures decreased more than the number of TAVR procedures (24.63% vs. 16.42% for the entire year 2020).
Conclusion:
The first year of the COVID-19 pandemic saw a substantial postponing of AVR procedures in Germany. Postponing was higher for sAVR than for TAVR procedures and less pronounced during the second wave of the COVID-19 pandemic.
Related Concept Videos
Aortic Regurgitation III: Medical Management
Aortic Regurgitation I: Introduction
Mitral Stenosis III: Medical Management
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Valve Prolapse II: Assessment and Management
Aneurysm IV: Nursing Management

